Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,464 | 86,877 | 38,863 | 32,109 | 82,609 |
| Marketable Securities | 298,570 | 267,611 | 205,531 | 264,316 | 246,279 |
| Receivables | 6,588 | 3,629 | N/A | N/A | N/A |
| TOTAL | $344,268 | $370,903 | $255,269 | $306,519 | $341,490 |
| Non-Current Assets | |||||
| PPE Net | 302 | 824 | 1,074 | 1,648 | 1,941 |
| Other Non-Current Assets | 6,309 | 1,721 | 3,017 | 3,749 | 4,494 |
| TOTAL | $6,611 | $2,545 | $4,091 | $5,397 | $6,435 |
| Total Assets | $350,879 | $373,448 | $259,360 | $311,916 | $347,925 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 9,589 | 11,613 | 11,613 |
| Accounts payable and accrued liabilities | 3,057 | 1,000 | 2,660 | 5,526 | 1,251 |
| Accrued Expenses | 27,701 | 27,172 | 23,570 | 34,459 | 29,452 |
| Other current liabilities | 20,327 | 17,013 | N/A | N/A | N/A |
| TOTAL | $51,085 | $45,185 | $35,819 | $51,598 | $42,316 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | 0 | 814 | 3,634 |
| Other Non-Current Liabilities | 245,658 | 246,734 | 196,819 | 196,735 | 197,358 |
| TOTAL | $245,658 | $246,734 | $196,819 | $197,549 | $200,992 |
| Total Liabilities | $296,743 | $291,919 | $232,638 | $249,147 | $243,308 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 226,604 | 226,227 | 226,219 | 225,582 | 225,409 |
| Common Shares | 23 | 23 | 23 | 23 | 23 |
| Retained earnings | -1,235,539 | -1,204,736 | -1,253,968 | -1,212,040 | -1,163,892 |
| Other shareholders' equity | -2,231 | -518 | -628 | -350 | -618 |
| TOTAL | $54,136 | $81,529 | $26,722 | $62,769 | $104,617 |
| Total Liabilities And Equity | $350,879 | $373,448 | $259,360 | $311,916 | $347,925 |